The pelvic reconstruction market is anticipated to flourish at an average CAGR of 2.8% between 2023 and 2033. The market is expected to hold a market share of USD 376.2 million by 2033, while the market is likely to reach a value of USD 285.6 million in 2023.
Vaginal sling systems are among the most widely manufactured pelvic reconstruction products worldwide. Vaginal slings use minimally invasive procedures that are less time-consuming and aid in treating conditions such as urinary incontinence.
These slings are placed in the urethra to keep the urethra in the correct position. As per the study, vaginal mesh and vaginal sling systems may continue to grow in the forecast period (2023 to 2033).
As per the National Center for Biotechnology Information, around 40% of women across the globe are affected with urinary incontinence. It is one of the key causes resulting in the need for pelvic repair due to abnormalities caused by these diseases.
To limit the condition, urethral sling procedures, also known as pubovaginal slings, are the most preferred among healthcare professionals. This is expected to aid the growth of the market.
| Attributes | Details |
|---|---|
| Pelvic Reconstruction Market CAGR (2023 to 2033) | 2.8% |
| Pelvic Reconstruction Market Size (2023) | USD 285.6 million |
| Pelvic Reconstruction Market Size (2033) | USD 376.2 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
According to Future Market Insights (FMI), pelvic reconstruction was nearly 1.1% of the USD 25.0 million global women's health devices market in 2022. The sales of pelvic reconstruction expanded at a CAGR of 2.3% from 2018 to 2022 due to the increasing prevalence of pelvic organ prolapse.
The demand for pelvic reconstruction procedures is expected to significantly increase due to growing pelvic floor problems such as vaginal prolapse, urinary incontinence, interstitial cystitis, and fistulae. Due to this, the demand for both surgical and non-surgical procedures is predicted to surge rapidly, fuelling the growth.
As per the study, the recurrence rate among patients is also high for pelvic organ prolapse. It is a highly common case in women; per the United States Department of Health and Human Services, pelvic floor disorders, including urinary incontinence and pelvic organ prolapse, affect one in five women.
The traditional treatment methods are replaced by robotic surgeries that are minimally invasive and lead to faster recovery. Also, with the complications associated with the use of synthetic mesh in pelvic floor repair, healthcare professionals are actively researching the use of biomaterials and cell-based therapies.
Further, tissue engineering using several different cell lines, including fibroblasts and adult stem cells, has been proposed to be used within the pelvic floor. Consequently, companies are investing extensively in research and technology to improve the treatment pattern and reduce the current treatment's risks and side effects.
Considering women's health and access to safe and effective medical devices, the United States Food and Drug Administration (FDA) are analyzing the benefit and risks of surgical mesh. In 2019, the FDA issued warnings about the risks associated with using transvaginal mesh used for pelvic organ prolapse (POP) repair with the use of certain devices.
Vaginal mesh, vaginal sling systems, and vaginal pessaries are projected to be in high demand in the forecast period as the prevalence of pelvic floor disorder rises. Vaginal sling systems are widely used owing to the minimally invasive procedure and increased cases of pelvic floor disorders, especially among the female population.
Owing to the aforementioned factors, the global pelvic reconstruction market is expected to record a CAGR rate of 2.8% during the forecast period.
Need for Alternative Procedure Due to Complexities in Current to Create Conducive Environment
Development and surveillance of novel tissue engineering procedures, such as cell-based therapies for pelvic floor reconstruction, are key factors creating lucrative growth prospects for the market.
As there are numerous complexities associated with the current procedures and with the prohibitions by the FDA for certain transvaginal mesh products, the demand for alternatives, such as tissue engineering procedures, may surge.
It is an innovative approach that could be worked upon immensely by the manufacturers for the increased growth in the market of pelvic reconstruction. This is expected to provide lucrative opportunities for growth in the overall pelvic reconstruction market.
Principal Consultant
Side-effects by Use of Surgical Mesh Might Impede the Growth
There is a decrease in products concerning pelvic reconstruction owing to the disapproval and ban of certain products by regulatory authorities such as the FDA. Some common complications reported include mesh erosion, infections, vaginal scarring, and a recurrence of urinary incontinence.
Several adverse events were reported with surgical mesh, a key restrain in the market growth. For instance, the POP Mesh Adverse Event Reports to the FDA, through January 31, 2019, were 139,000 for mesh products, over 132,280 of these were injuries and 1,107 patients died. These factors are likely to affect the pelvic reconstruction market negatively.
| Country | Revenue Share % (2022) |
|---|---|
| United States | 29.7% |
| Germany | 5.1% |
| Japan | 3.2% |
| North America | 33.9% |
| Europe | 26.5% |
| Country | CAGR % (2023 to 2033) |
|---|---|
| China | 3.5% |
| India | 3.7% |
| United Kingdom | 2.3% |
| Australia | 3.0% |
Ongoing Product Development and Research Activities by Leading Companies to Augment Growth
The United States held around 29.7% of the global pelvic reconstruction market in 2022. The North American region held a market share of 33.9% in 2022. As per the study, many women in the United States face the complexities of pelvic organ prolapse (POP). This is resulting in high demand for pelvic reconstruction procedures.
To capitalize on this growing demand, leading players such as Johnson & Johnson and Boston Scientific are investing in research and development to develop efficient procedures. For instance, in July 2022, a leading player in the United States, Onkos Surgical, announced the approval of its My3D Personalized Pelvic Reconstruction System.
It is a first-of-a-kind solution that provides 3D-printed implants, models, and instruments and an advanced planning service to treat deformities, revisions, and diseases efficiently.
The implants are designed and manufactured with unique features that provide an accurate way for anatomic restoration. Hence, a slew of such developments in the United States may boost the market.
Rising Incidence of Pelvic Disorders in the United Kingdom to Propel Demand
The United Kingdom dominated the Europe pelvic reconstruction market with a total market share of about 24.1% in 2022 and is expected to witness an average CAGR of 2.3% between 2023 and 2033. Rising cases of pelvic floor disorders in the country underpin growth in the market. As per the BMJ, in 2022, around 5 million women in the United Kingdom experience pelvic floor dysfunction.
With burgeoning cases of pelvic disorders, the need for non-invasive pelvic reconstruction procedures is expected to surge. Hence, numerous key players are eyeing the United Kingdom market to capitalize on this trend and gain revenue.
Besides this, the availability of favorable reimbursement policies in the United Kingdom's healthcare infrastructure is aiding the growth of the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Category | By Product Type |
|---|---|
| Leading Segmente | Vaginal Sling Unit |
| Market Share (2022) | 54.20% |
| Category | By Procedure Type |
|---|---|
| Leading Segmente | Surgical |
| Market Share (2022) | 78.9% |
Vaginal Sling Systems to Remain the Most Preferred Procedure for Pelvic Reconstruction
Based on product type, the vaginal sling systems segment held a market share of 54.20% in 2022. The segment contributed revenue of around 54.2% of the demand share in 2021. Vaginal sling systems are preferred as it is considered the best option for the minimally invasive procedure and has a short patient recovery time.
Increasing POP Cases to Propel the Need for Surgical Procedures
Surgical procedures held a revenue share of 78.9% in 2022, and the segment is predicted to expand positively due to the success rates for reconstructive surgeries. With rising cases of pelvic floor disorders, the need for surgical procedures is growing as it is proven to be the most successful and preferable way to treat the disorder.
In terms of indication, pelvic organ prolapse is the most common indication globally. The segment held a market share of about 53.7% in 2021. An increase in pelvic organ prolapses due to aging and trauma during childbirth, such as difficult labor, obesity, chronic cough, or chronic constipation, may aid the demand for pelvic reconstructive surgeries.
Hospitals held a huge market share of 48.9% in 2022, per Future Market Insights (FMI). The growing prevalence of pelvic floor disorders and the increase in surgical and non-surgical procedures are driving the growth in the segment. Due to the easy availability of all advanced products and healthcare equipment, the adoption of pelvic reconstructive products has surged in hospitals worldwide.
Further, skilled professionals and on-call surgeons are available in hospitals, especially in developed countries such as the United States and the United Kingdom. Additionally, in emerging economies such as India and China, patients can avail of reimbursement policies, which makes the surgical procedure in hospitals cost-effective. This may boost the growth in the segment.
The pelvic reconstruction production industry is highly fragmented, with numerous competitors. Leading manufacturers are adopting strategies like enhanced research and development and expansion to meet consumer demand and grow their customer base.
For instance:
Key Players
The market held a value of USD 277.8 million in 2022.
The market holds a value of USD 285.6 million in 2023.
The market is anticipated to hold a share of USD 376.2 million by 2033.
The market is expected to have a CAGR of 2.8% by 2033.
The vaginal sling system segment leads the market as it held a market share of 54.20% in 2022.
The surgical segment leads the market as it held a market share of 78.9% in 2022.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Vaginal Mesh 5.2. Vaginal Sling Systems 5.3. Vaginal Pessary 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Procedure 6.1. Non-Surgical 6.2. Surgical 6.3. Native Tissue Repair 6.4. Colporrhaphy 6.5. Sacrocolpopexy 6.6. Sacrohysteropexy 6.7. Transvaginal Graft 6.8. Sling Surgery 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Indication 7.1. Pelvic Organ Prolapse 7.2. Vaginal Prolapse 7.3. Rectal Prolapse 7.4. Urinary Incontinence 7.5. Interstitial Cystitis 7.6. Fistulae 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Pelvic Organs 8.1. Uterus 8.2. Ovaries 8.3. Vagina 8.4. Fallopian Tubes 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 9.1. Hospitals 9.2. Ambulatory Surgical Centers 9.3. Specialty Clinics 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Western Europe 10.4. Eastern Europe 10.5. South Asia and Pacific 10.6. East Asia 10.7. Middle East and Africa 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 18. Key Countries Market Analysis 19. Market Structure Analysis 20. Competition Analysis 20.1. Johnson & Johnson Services Inc. 20.2. Coloplast A/S 20.3. Dipromed Srl 20.4. Boston Scientific Corporation 20.5. pfm medical ag 20.6. Betatech Medical 20.7. Promedon Group 20.8. Caldera Medical 20.9. Cook Medical 20.10. MEGYN PRODUCTS INC. 20.11. CooperSurgical Inc. 20.12. DIMA S.L. 20.13. Digitimer Ltd 20.14. Bray Group Ltd 20.15. medesign Ingenieur-Consulting GmbH 20.16. Panpac Medical Corp. 20.17. Bioteque America Inc. 20.18. Mediplus Ltd. 20.19. Nomadic International 20.20. Dyna Mesh 21. Assumptions & Acronyms Used 22. Research Methodology
Explore Healthcare Insights
View Reports
Pelvic Reconstruction Market
